Goodkin, Donald E.

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 6,969

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 334

Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.

Mohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology

Digital Mental Health InterventionsMultiple Sclerosis Research Studies

Cited by 240

Drugs Used to Treat Spasticity

Kita, M., & Goodkin, D. E. (2000) · Drugs

Botulinum Toxin and Related Neurological DisordersCerebral Palsy and Movement Disorders

Cited by 172

Treatment of depression in multiple sclerosis: Review and meta-analysis.

Mohr, D. C., & Goodkin, D. E. (1999) · Clinical Psychology: Science and Practice

Multiple Sclerosis Research StudiesTreatment of Major Depression

Cited by 155